IL6 and breast cancer: In conclusion, our study has identified key secretory factors (IL-6 and G-CSF) as mediators of taxane-induced dormancy awakening in a breast cancer model (Fig 8) and a meta-analysis of 10-gene signature predicting recurrence free survival outcomes in patients receiving chemotherapy (Fig 7A).